As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amgen: Hsbc Holdings PLC, Ikarian Capital LLC, SummitTX Capital L.P., Tudor Investment Corp ET AL, Millennium Management LLC, Caption Management LLC, Balyasny Asset Management L.P., Boothbay Fund Management LLC, Alphadyne Asset Management LP, BTG Pactual Asset Management US LLC, Royal Bank of Canada, ADAPT Investment Managers SA, Squarepoint Ops LLC, Verition Fund Management LLC, Walleye Trading LLC, PEAK6 LLC, Maven Securities LTD, Barclays PLC, Walleye Capital LLC, Kopernik Global Investors LLC, Wells Fargo & Company MN, Jane Street Group LLC, Marex Group plc, Bank of Montreal Can, XY Capital Ltd, Group One Trading LLC, Mirae Asset Securities USA Inc., All Terrain Financial Advisors LLC, Simplex Trading LLC, Allianz Asset Management GmbH, JPMorgan Chase & Co., Twin Tree Management LP, Lido Advisors LLC, Goldman Sachs Group Inc., BNP Paribas Financial Markets, Tennessee Valley Asset Management Partners, Delta Accumulation LLC, and Delta Accumulation LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.